Centre for Outcomes Research and Evaluation (CORE) - GUEST Speaker Seminar (October 9, 2018)
 |
Randomized trials versus “real world” data? Why do they differ?
Learning Objectives
Using as examples biologics and new targeted synthetics in the management of rheumatoid arthritis
- Understand differences between randomized trials for regulatory approval and real-world studies;
- Describe why the results of real-world trials and registries differ from those of regulatory trials;
- How can real-world studies guide practice using rheumatoid arthritis management as an example?
Presenter: Claire Bombardier, MD, FRCP(C)
Professor of Medicine, University of Toronto
Senior Scientist, TGRI, UHN
Rheumatologist, Mt Sinai Hospital
When: Tuesday, October 9, 2018 at noon
Where: 5252 Boulevard de Maisonneuve West, 3rd Floor (3B kitchen)
Information: CORE 514-934-1934 ext. 48292 or Core.mailer@rimuhc.ca
The presentation will be delivered in English.
|
